Cure My Disease

Don't miss your cure!

Home News Browse Soon ready About
Log in / Sign up
← Back to home

Jiangsu Cancer Institute & Hospital

Clinical trials sponsored by Jiangsu Cancer Institute & Hospital, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

  • New pill combo offers hope for Hard-to-Treat esophageal cancer Results expected Dec 2026 (estimated)
  • New study aims to unlock clues in nasopharyngeal cancer Results expected Jun 2027 (estimated)
Browse trials soon ready across all sponsors →
Trials to join now! 4 Not yet recruiting 7 Not yet finished but already full! 2 Completed 1
Sort by
  • Triple threat before surgery: could a new combo wipe out stomach cancer cells?

    Disease control Completed

    This study tests whether giving a three-part treatment before surgery can improve outcomes for people with locally advanced stomach or gastroesophageal junction cancer. The treatment combines an immunotherapy drug (tislelizumab) with standard chemotherapy and a short course of ra…

    Phase 2 • Sponsor: Jiangsu Cancer Institute & Hospital • Aim: Disease control

    Last updated Jul 04, 2026 00:00 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse Glossary About Terms of use Contact us

This is a site from Cyber and Space